Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06612541 · ClinicalTrials.gov registry record
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
A clinical trial of Retinopathy of Prematurity (ROP) and ROP Examination, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT06612541 is a study of Retinopathy of Prematurity (ROP) and ROP Examination that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 90 participants, below the 2,529-participant average among 3 other Retinopathy of Prematurity (ROP) trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06612541, a study of Retinopathy of Prematurity (ROP) and ROP Examination, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2030-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06612541
The ClinicalTrials.gov registry entry for NCT06612541 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,529-participant average among 3 other Retinopathy of Prematurity (ROP) trials with a reported enrollment target (96% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Retinopathy of Prematurity (ROP) appearing as the primary indexed condition, and to 0 interventions.
NCT06612541 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT06612541 about?
NCT06612541 is a clinical study titled "Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity". The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has no...
What is the current status of trial NCT06612541?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2025-02-01. Estimated completion is 2030-02.
What conditions does trial NCT06612541 study?
This clinical trial studies the following conditions: Retinopathy of Prematurity (ROP), ROP Examination.
Who is sponsoring clinical trial NCT06612541?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06612541 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinopathy of Prematurity (ROP)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.